4//SEC Filing
Heller Kevin N. 4
Accession 0001213900-22-014568
CIK 0001788028other
Filed
Mar 22, 8:00 PM ET
Accepted
Mar 23, 6:04 PM ET
Size
5.7 KB
Accession
0001213900-22-014568
Insider Transaction Report
Form 4
Heller Kevin N.
EVP, Research and Development
Transactions
- Award
Stock Option (right to buy)
2022-03-21+7,500→ 7,500 totalExercise: $3.54Exp: 2032-03-21→ Voting Common Stock (7,500 underlying)
Footnotes (1)
- [F1]1/4th of the shares subject to the option shall vest on December 7, 2022, and 1/48th of the shares subject to the option shall vest following each one-month period thereafter, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive.
Documents
Issuer
Jasper Therapeutics, Inc.
CIK 0001788028
Entity typeother
Related Parties
1- filerCIK 0001775716
Filing Metadata
- Form type
- 4
- Filed
- Mar 22, 8:00 PM ET
- Accepted
- Mar 23, 6:04 PM ET
- Size
- 5.7 KB